Literature DB >> 26646815

Lupus anti-ribosomal P autoantibody proteomes express convergent biclonal signatures.

M A Al Kindi1, A D Colella2, D Beroukas1, T K Chataway2, T P Gordon1.   

Abstract

Lupus-specific anti-ribosomal P (anti-Rib-P) autoantibodies have been implicated in the pathogenesis of neurological complications in systemic lupus erythematosus (SLE). The aim of the present study was to determine variable (V)-region signatures of secreted autoantibody proteomes specific for the Rib-P heterocomplex and investigate the molecular basis of the reported cross-reactivity with Sm autoantigen. Anti-Rib-P immunoglobulins (IgGs) were purified from six anti-Rib-P-positive sera by elution from enzyme-linked immunosorbent assay (ELISA) plates coated with either native Rib-P proteins or an 11-amino acid peptide (11-C peptide) representing the conserved COOH-terminal P epitope. Rib-P- and 11-C peptide-specific IgGs were analysed for heavy (H) and light (L) chain clonality and V-region expression using an electrophoretic and de-novo and database-driven mass spectrometric sequencing workflow. Purified anti-Rib-P and anti-SmD IgGs were tested for cross-reactivity on ELISA and their proteome data sets analysed for shared clonotypes. Anti-Rib-P autoantibody proteomes were IgG1 kappa-restricted and comprised two public clonotypes defined by unique H/L chain pairings. The major clonotypic population was specific for the common COOH-terminal epitope, while the second shared the same pairing signature as a recently reported anti-SmD clonotype, accounting for two-way immunoassay cross-reactivity between these lupus autoantibodies. Sequence convergence of anti-Rib-P proteomes suggests common molecular pathways of autoantibody production and identifies stereotyped clonal populations that are thought to play a pathogenic role in neuropsychiatric lupus. Shared clonotypic structures for anti-Rib-P and anti-Sm responses suggest a common B cell clonal origin for subsets of these lupus-specific autoantibodies.
© 2016 British Society for Immunology.

Entities:  

Keywords:  mass spectrometry; ribosomal P; systemic lupus erythematosus

Mesh:

Substances:

Year:  2016        PMID: 26646815      PMCID: PMC4778099          DOI: 10.1111/cei.12750

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins.

Authors:  R H Scofield; A D Farris; A C Horsfall; J B Harley
Journal:  Arthritis Rheum       Date:  1999-02

Review 2.  Predicting vaccine responsiveness.

Authors:  Scott D Boyd; Katherine J L Jackson
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

3.  Anti-ribosomal antibodies bind the Sm proteins D and B/B'.

Authors:  L Caponi; S Bombardieri; P Migliorini
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

4.  Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus.

Authors:  K Elkon; S Skelly; A Parnassa; W Moller; W Danho; H Weissbach; N Brot
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Lupus anti-ribosomal P peptide antibodies show limited heterogeneity and are predominantly of the IgG1 and IgG2 subclasses.

Authors:  E Bonfa; J L Chu; N Brot; K B Elkon
Journal:  Clin Immunol Immunopathol       Date:  1987-10

6.  Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region.

Authors:  Benjamin F Bruner; Donny M Wynn; Morris Reichlin; John B Harley; Judith A James
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 7.  Restricted, canonical, stereotyped and convergent immunoglobulin responses.

Authors:  Carole J Henry Dunand; Patrick C Wilson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

8.  Serum SmD autoantibody proteomes are clonally restricted and share variable-region peptides.

Authors:  Mahmood A Al Kindi; Tim K Chataway; George A Gilada; Michael W Jackson; Fiona M Goldblatt; Jenny G Walker; Alex D Colella; Tom P Gordon
Journal:  J Autoimmun       Date:  2015-01-07       Impact factor: 7.094

9.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

10.  Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis.

Authors:  Soledad Matus; Patricia V Burgos; Marcela Bravo-Zehnder; Regine Kraft; Omar H Porras; Paula Farías; L Felipe Barros; Fernando Torrealba; Loreto Massardo; Sergio Jacobelli; Alfonso González
Journal:  J Exp Med       Date:  2007-12-03       Impact factor: 14.307

View more
  3 in total

1.  Precipitating anti-dsDNA peptide repertoires in lupus.

Authors:  J J Wang; A D Colella; D Beroukas; T K Chataway; T P Gordon
Journal:  Clin Exp Immunol       Date:  2018-10-11       Impact factor: 4.330

Review 2.  Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus.

Authors:  Erica Moore; Michelle W Huang; Chaim Putterman
Journal:  Curr Opin Rheumatol       Date:  2020-03       Impact factor: 4.941

3.  Method development of immunoglobulin G purification from micro-volumes of human serum for untargeted and targeted proteomics-based antibody repertoire studies.

Authors:  Yu-Ting Chang; Ming-Chu Chang; Yun-Jung Tsai; Christine Ferng; Hsi-Chang Shih; Ya-Po Kuo; Chung-Hsuan Chen; I-Lin Tsai
Journal:  J Food Drug Anal       Date:  2018-10-27       Impact factor: 6.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.